ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimm...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Acupressure reduced fatigue in breast cancer survivors

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Omega-3 fatty acid stops known trigger of lupus

Print Page
Email Article

Scientists discover key molecule in transmission of AIDS virus

  [ 64 votes ]   [ Discuss This Article ] • August 8, 2000

Scientists have discovered a key molecule that the AIDS virus uses to hijack a special type of cell in the body's outermost tissues, providing vital information into how the virus is first transmitted in the body. The molecule transports the virus to immune system tissues, and actually facilitates infection.

The findings, by scientists at New York University School of Medicine and University Hospital Nijemgen in the Netherlands, provide a new explanation as to how the virus gets into the body and makes its way to tissues where immune system cells reside. The AIDS virus then infects immune cells and eventually overwhelms the body's ability to fight infection.

This research shines a spotlight on the first encounter between HIV and cells in the body. It offers fresh avenues of research for developing innovative treatments for AIDS, and may lead to vaccines that could prevent the virus from gaining access to the body's immune cells. It is far too early, however, to determine whether the current finding will lead to new treatments.

In a study published in the March 3 issue of the journal Cell, researchers report that when HIV is deposited in the mucosal tissue lining the rectum and vagina, the first sites exposed to sexually transmitted infection, it binds specifically to a specialized type of cell, called a dendritic cell, by way of a molecule on the surface of this cell. The virus, which is now bound to this molecule, is then ferried to areas of the body rich in T-lymphocytes, the cells that are ultimately infected by the bound HIV. The molecule has been named DC-SIGN.

The research teams were led by Dan R. Littman, M.D., Ph.D., Helen L. and Martin S. Kimmel Professor of Molecular Immunology and Professor of Pathology at NYU School of Medicine, and a Howard Hughes Medical Institute Investigator, and by Dr. Yvette van Kooyk at University Hospital Nijmegen in the Netherlands.

Scientists had previously suspected that the AIDS virus interacted with dendritic cells. The current findings show how the interaction occurs. A protein (gp120) on the surface of HIV latches onto DC-SIGN, a receptor on the surface of dendritic cells. Receptors are like locks; only certain keys will fit into them. In the case of DC-SIGN, however, the key doesn't open the lock. Instead, once the virus is bound to DC-SIGN, it is transported to lymph nodes, where the dendritic-cell complex presents the virus to immune cells, particularly T-lymphocytes. T-cells have a different receptor system to which the virus binds, and this system allows the virus to infect T-cells.

"We feel these findings are very exciting and are likely to provide us with vital information into how the virus is first transmitted and amplified in the body," says Dr. Littman. "We have identified the key molecule that HIV uses to hijack dendritic cells. The virus subverts the normal function of these cells, which is to protect the body from infection."

In the current study, the scientists report that the dendritic cells bearing the cell-surface receptor DC-SIGN are especially abundant at mucosal sites in the rectum, uterus, and cervix, and they show that the AIDS virus is remarkably durable when bound to the receptor. HIV is a rather brittle virus, but once bound to the receptor, it becomes far more long lived. The scientists speculate that DC-SIGN protects the virus from decay.

In the study, the scientists also generated antibodies in the laboratory that were directed against DC-SIGN. The antibodies blocked the cells' ability to bind to HIV, potentially providing an avenue to develop therapies or a vaccine that could thwart HIV infection in the body.

Dendritic cells are a subset of immune cells that present foreign proteins or antigens to another group of cells called T-lymphocytes, the foot soldiers of the body's immune system and the ones targeted by HIV. Once the antigen is presented, T-cells go into action, marshalling recruits to battle a foreign foe with special messenger molecules called cytokines and chemokines.

Previously, Dr. Littman and colleagues discovered that HIV must bind to chemokine receptors on the surface of T-cells in order to enter the cell. Now, with the new discovery, he and his colleagues have found an even earlier event in HIV's battle plan.

"Our data suggest that after HIV has been ferried by dendritic cells to the lymph nodes, the bound virus particle is presented to the chemokine-receptor complex on T-cells, greatly enhancing the entry of viral particles into these cells," says Dr. Littman.

The current studies were performed with cultured cells in the laboratory, and scientists now need to validate their findings in people infected with HIV. Dr. Littman says he would like to learn whether there are variations in DC-SIGN that make dendritic cells resistant to the AIDS virus. People who have these variations would potentially be naturally resistant to HIV infection, despite being exposed many times to the virus.

This information potentially could be used to design vaccines that will elicit antibody responses that block the interaction of HIV with dendritic cells and to develop new therapies that will interfere with the amplification of the HIV replication process by dendritic cells, says Dr. Littman.

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Ultra ATP+, Double Strength Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Breaking Through the Mental Fog Breaking Through the Mental Fog
Sunshine Vitamin Has D-lightful Health Benefits Sunshine Vitamin Has D-lightful Health Benefits
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map